NGF-response of EGF-dependent progenitor cells obtained from human sympathetic ganglia by Silani, V. et al.
SIGNAI.UNC moleculcs are [hought to playa signi6cant 
role in lIetcrmining thc fate or neural erest progenito r 
cells. Thc human sympathetic chain was identined at 6.5, 
7.5,8.2, 10.2 and t 1.4 postconccption (Pe) wecks dcmon-
strating low af6nity nerve growth factor (NGF) rtcep-
tors, and was proccssed for liuue culture.ln thc prescnee 
of epidermal growth factot (EGF), floating sphercs or pro-
lifcrating rrogcnitor eells wen dc:vdoped in vitro. In thc: 
absence: 0 EGF progenitor cdls diffc:rc:ntiated ioto t yro-
sine: hydroxylasc: (TH)-immunorc:activc: neu ronal and 
TH-nc:gativc: fial cells. NGF [rUlment signi6cantly 
incrcasc:d neurite outgrowth and surviv.al of TH-immu-
norcactivc cdls. Thc multipolent eells wc isolatcd differ 
from prniously rcporte<! sympathoadrenal progeniton 
in that they give rise to TH immunoreactive neurones pre-
cociously sensitive to NGF. 
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Introduction 
Sympathoadrenal (SA) lineage is a neural <:rest 
derivative that has been investigated in detail. ' It differ-
entiates to form sympathetie neurones, the adrenal 
gland primordia (then ch romafhn cells) and the small 
intensely fluorescent (SIF) cells. A peeuliar feature of 
these cell types is their ability to be phenotypically 
interconverted by speeific environmental signals. l The 
plasticity is supposed to reflect the development from a 
common embryonic progenitor celP-s NGF, along 
with glucosteroids, is one of the most important 
environmental determinants of the cell fate in vivo ....... ' 
Recently, investigators were able to establish a v-myc-
immortalized SA progenitor eell line9 and isolate a 
common stemcell for neu rones and glia from the mam-
malian neural erest.' ~ 
Thc purpose of the prcscnt study was to obrai n 
EGF-responsive progenitor cells from the human 
developing sympathetic autonomie chain, according to 
the experimental procedure described for the murine 
central nervous system by Reynolds and Weiss." Spe-
cihe features such as TH expression and early NGF 
response with neu rite outgrowth and increased sur-
vival, were used as speeihc functional assays for the 
NGF-response of EGF-
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neural derivatives obtained from the EGF-dependent 
progenitor cells we were able to isolate. 11 
Material and Methods 
Human embryonic tissues were obtained from 
patients undergoing therapeutie abortions according 
to the current Ital ian laws. The Institutional Ethical 
Commiuee approved the experiments and informed 
eonsent from the patients was obtained. 
Staging o[ human embryos: Thc age of thc embryos was 
determined by preoperative ultrasound scanning, 
wh ich allowed a good estimation of embryonic erown-
rump length (CRL) and staging bcfore the embryo was 
obtained by suction abortion. Other distinguished fea-
tures, such as foot length, hand morphology, last men-
strual period (LMP) and staging of developmem 
accord ing to the Carnegie Collection eriteria'l were 
rccorded for embryos you nger than PC week 8. For 
PC age > 8 weeks, donors were staged by LMP and 
CRL as determined uhrasonically in utero.'· Sono-
graph ie measurements were able tO predict the ges-
tational age from 8.0 to 12.6 wecks with an accuracy of 
::!: 4 days . '~·" The age of theembryos was estimated by a 
eombination of the above features and expressed as a 
PC weck. PC wecks and days were derived from CRL 
values as previously reported. u 
Localization of the ganglia in the sympathetic auto-
nomicchain by fluorescence microscopic detection o{ the 
low affinity NGF receptors (p'J .. \.C1'~): Specimens were 
immediatcly immersion-fixed for 12-24 hin 4% para-
formaldehyde, ri nsed, cryoprotecled in increasing 
sueroseeoncemration (7-15%), and frozen in ethanol-
liq uid ni trogen. Spinal cord, dorsal root ganglia and 
sympathetic ganglia were shown in the same specimen. 
Frozen 16 JLm horizontal sections were cryostal sec-
tioned (rop Cryo E, Pabiseh) and treated for immuno-
histochemical studies. For the low affi nity p'~NW.R 
localization, twO specific monoelonal antibodies 
anti_p')-NGfR (from elones ME 2004 (Amersham) and 
821 1 (Boehringer Mannheim, IN) respectivcly) were 
used. Sections were washed with PBS, overlaid with 
mouse anti_p' .... SGFII dil utcd 1:50 in PBS overnight at 
4°C, washed with PBS, added with FITC anti-mouse 
IgG (1:40 in PBS) for I hat 4°C, and then washed three 
times with PBS and mountcd . Sections were examined 
on a Zeiss transmincd- light photomicroscope 111 
equipped with an epi-fl uorescence condenser. 
ECF-dependent progenitor cell isolation in vitro: To 
obtain SA cells, specimens at PC weck 6.5, 7.5, 8.2,10.2 
and 1104 were collected in sterile Hank's balanced sah 
solution, pH 7.4 (Gibco) and immed iatcly processed 
for tissue euhure. The SA system was isolated using 01. 
sterile technique, under an inverted microseope. After 
careful dissection of the nervous tissue from meninges, 
vessels and any other contaminants, sympathetie gan-
glia were isolated and immed iately cut into picces using 
seissors. Tissues were then added with Dulbecco's 
modified Eagle's medium and FI2 nutricnt (1:1, viv; 
Sigma) supplemented with antibioties and glucose (5 
mg I-I). A defined hormone and sah mixture (defined 
supplements) that ineluded insu lin (25 J.l.g mi-I), trans-
ferrin (100 JLg mi-I) progesterone (20 nM), putresci ne 
(60 JoLM), and sclenium chloride (30 nM) was used in 
place of serum. Trypsin (11 , Sigma) at a low coneen-
tration (0.08%, v/v) was used to facibtate cell dis-
sociation. Tissues were incubated for 15-20 min at 
36SC in 5.5% CO/, before trypsin was removed. Dis-
persed eells were centrifuged (500 x g for 10 min) far 
pellets and resuspended in DMEM/FI2 and gendydis-
soeiated by trituration with Pasteur pipenes of pro-
gressively smaller bore size. Disperscd cells were thcn 
plated without any attaehment faeto r. An average 
viable cell number of 4 x 10' was obtained from a single 
ganglion. Ten thousand eells were plated in a 16 mm 
dish in DMEM/FI2 medium with defined sup-
plements and 20 ng ml-1 human recombinant epidermal 
growth faetor (EGF, Boehringer Mannhei m, IN) in thc 
absence of serum. After 8- 10 days in vltro, lloatingeell 
clusters (spheres) were collccted, centrifugcd at 500)( g 
for 10 min, resuspended in EGF-frec medium and then 
meehanically dissociated to single cells. Isolated EGF-
dependent progenitor eells were subcu hured in the 
presencc of EGF-DMEM/F I2 with defined sup-
plements tO obtain second passage spheres (repeatcd 
passagcs). Spheres were subsequently dissociated to 
singlecclls and plated at adonaldensityof 100 ~ 6cells 
on 35 mm Falcon dishes, pre-coated ovcrnight with 
poly -L- Iysi ne (mol wt 90000- 120000, 10 JoLg mi-I in 
0.15 M sodium borate buffer, pH 804). Cuhures were 
ineubated at 36.5°C in a humidified atmosphcre of 
5.5% CO/. Every 2-3 days half of the medium was 
removed from cach weil :tnd replaeed with an equal 
volume of fesh medium (DMEM/FI2) with defined 
supplements, in the absence of EGF. 
NGF treatment o{ the progenitor cells and morphologi-
cal e'f.Ialuation: 75 NGF (30 ng ml-' final eoncentr:ttion, 
Sigma) was added to the eultures on the fi rst in vltro 
day, 2 h after plati ng. Cells were observed every 4-6 h 
using an inverted microseope for the first 24 h. Cel l 
counting was performed after 6 and 12 days in vitra 
using an inverted microseope with phase contrast 
objectives and a high numerical opening, magnification 
)( 320. Selected areasof each weil (approxi mately 7% of 
the 35 mm weil surface) were seanned for the presencc 
of ph:tse-bright cells with/without neurites at 6 and 12 
days in vitro to determinc both survival rates (number 
of neurones which h:tve survived in the preseneel 
absence of NGF) and the percentage of neu rones with 
neurites (proecsses more th:tn a eel l diameter in length). 
Approximately 500 viable EGF-dependent progenitor 
eells (clonal lines) were monitored between 0 and 12 
days in vitro both in NGF-treated and control 
cu ltures. 
Immunocytochemisl ry of progenilor ceUs in culture: 
Progenitorcells were fixed with 4% paraformaldehyde 
for 1 hand permeabilizcd with 0.1 % Triton X-IOD for 
30 min. After adding goat serum, cuhures were ineu-
bated with an anti-TH monoelonal or polyclonal anti-
body (monoclonal from Inestar and polyelonal from 
Eugene Tech, 1: 100 and 1:500 dilution, respectivcly) 
and, subsequcntly, with goat FITC eonjugated anti-
mouse IgG (1:100) (bioYeda). Progenitor cells were 
fixed both after 0 days in vitro, immediatel y after 
attachment (2-3 h), and at 6 days in vitro. 
Results 
From PC weck 6.5 tO 11 .3 p')..NGI-1I immunoreactivity 
was localizcd in the ganglia of the sy mpathetic auto-
nomie ehai n symmetrieally positioned in front of the 
vertebrae. Three anatomiea! regions were analysed 
(eervical, dorsal and lumbar spinal cord) :tnd p')..:-IGH 
was found in 01. 11 of them in eorrespondenee to the 
primitive sympathetic chain. Anatomical land marks 
such as vertebral bod ies were used for disseeti ng sym-
pathetic gangl ia (Fig. 1). p')..:-IGIIl expression was also 
FIG. ,. Mierogrephllof 11 lIympathetK: autonomieehain glnglion (Bill at 
pe _k 8.5 showing immunonuorescenca staininglor p-~. Ana-
tomical land marks Ivertab,el body. vblWil,a usad 10 loealiza the sym· 
pathalie ehain be/ore dissection. MIIgnific&tion: w 70. 
found in thc dorsal root ganglia and in the grey matter 
of the ventral spinal cord (data not shown). Dissociated 
sympathetic cells were obtained from pe weeks 6.5 to 
11.4. In the presence of DMEM/ FI2 with defined sup~ 
plements and EGF, floating spheres of proliferating 
cells were easily identified by contrast microscopy 
after 8-10 days in vitro, regardless of gestational age 
(Fig. 2). Second passage spheres were used for cell dis-
persion. Dissociated EGF-dependent progenitor cells 
were plated in the presence of an attachment bctor, 
polY-L-lysine. One hour after plating, progenitor cells 
were attached to the substrate. TH immunoreactivity 
was present soon after auachment (1-2 h; Fig. 3). 
Approximatcly 500 viable progenitor cells (clonal 
lines) were monitored in bOlh NGF-lreated and 
untreated control cultures. At 1 day in vitra, all viable 
cells (phase-bright, regular membrane, no granular 
dcposits) were classified in two different cell types: l1at, 
no n-neuronal protoplasmic cells and cells with Cl 
phase-bright cell body and neuronal-like processes 
(Fig. 'A, B). 
In all the progenitor clones, TH immunoreactivity 
was present in all of the sympathetic phase-bright neu-
ronal-like cells. No TH immunoreactivity was 
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FIG. 2. Second passage nORling clusterll (splMt'ell of h,EGF·depeno.nt 
p.ogenito. ceBs lifte. 8--'0 dllYs in vitro. Mignificetion:" 55. 
FIG. 3. TH immunoreactivity 01 hrEGF-depen.dent progenito' cell. 2 h 
Ifter IIttachment .fter sphere dispe~ion. MlIgnificlltion:" 275. 
ohserved in flat, protoplasmic, presumahly gHa, cells. 
Furthermore these ceHs tended 10 proliferate. Each 
clonalline(500 x 2 progenitors) we monitored gave rise 
to hoth cell phenotypes that tended to grow in close 
cellular interaction in 57 ~ 7% s.d. of the dones. At 6 
days in 'Vitra aher sphere dispersion, the percentage of 
surviving neuronal cells was 37 ~ 8% in the comrols 
and 89 ~ 4% in the NGF-trcated cuhures (Fig. 5A). 
The numher of surviving neurones at 12 days in 'Vitro 
was further reduccd in untrealed (22:!:: 3%) compared 
FIG. 4. Effact 01 NGF on neurila ou!groWlh: controll"'l end NGF (30 ng 
ml·'1 (81 trellled teil. IIfter 6 dllYs in vitro after sphere dilpersion. In Ihe 
eonlrollAI.1I neuroneHilr.e cells (e"owl wi'houl neulite outgrOWlh i. 
shown. FIlii non·neuronal plotoplasmic teilS were der,ved Irom the 
eommon EGF·OOpandent progenilor. Megnificetion: " 1 '0. 
with NGF-treated cuhures (69 :!: 4%). An average of 
67 :!: 8% cells showed extens ive neurite outgrowth 
after NGF treatment compared with the 8 :!: 3% of the 
controls (Figs 48, 58). Neu rites of the NGF-treated 
neurones tend to fascicu late and TH immunoreactivity 
was demonstrated both in thc soma and along the cell 
processes (fig. 6A, B). 
Discussion 
This study demonstrates that it is possible to isolate, 
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FIG. 5. (AI Survlvlng n .... tones aher Gd'". in v!trol.her 5ptltte dlsper • 
• ionl: NGF tt .. tm.nt eompi ... d with control • . (11 Eff~s 01 NGF on 
neurile oUlgrowth (morethen one cell di.meter In lengthlev.fueted et 
6 devs in vitro .her .pl"le,e dispersion. 
thetic progenitor cell from human embryos, which can 
potentially differentiate into at least twO different cell 
phenotypes in the presence of attachment factor(s). 
The neuronal-li ke cd ls we obtained from the EGF-
dependent progenitor cell were already eommitted 
(early immunoreactivity for TH) and promptly 
responded 10 NGF invitro with hoth neurite extension 
and inereased survival. 
At the gestational age we considered, the SA system 
alrcady migrated to thc adrenal gland, originating 
ehromaffin eellsY On the other hand. the EGF-
dependent progenitor cell does not represent a late 
stage in neural erest eeH differentiation because it 
retains the ability to generate other neural crest deri va-
tives such as non-neuronal cells.'o H owcver, its be-
haviour is different from that already reported for SA 
progenitors both from embryonic adrenal glands that 
were initially unresponsive to NGF/ and from thc SA 
progenitor cell line MAH (v-myc- infected. ad renal 
derived-HNK- J- positive cells) that failed to respond 
to NGF.' 
Different molecu les, including basic fibrob lasl 
growth factor (FGF). interleukin-6, IGF- l and VIP, 
have been reported to induce initial neuronal differen-
tiation of SA progenilors.'a-10 Furthermore, FGF and 
neurotrophin-J were recently reported toinduce NGF 
responsiveness of SA progenitors aftcr induction of the 
p"Otrk receptor exprcssion.~'·.!l O ur resuhs SUggC5t that 
FIG. 6. TH imml,lnor"eli"ity 01 NGF tlim ... leted Iympllhe lic neuron.1 
ce lls'l 6 dly. in vitro ,her .pl"lere dispersion. (Al phe" contrlS!; 18) TH 
'Ieining. Magnificelion: . 140. 
preueatment with EGF may be one of the factors 
responsible for the induction of early NGF sensitivity 
in human sympathetic progenitors, after quantitative 
modulation of signaluansduction through growth fac-
tor receptors. 
The repertoire of neurotransmitter fates available to 
the EGF-dependent SA progenitor cell seems to be re-
stricted to the catecholaminergic type, unlike that 
reported for other SA progenitors such as MAH cells, 
that have serotonergie as weil as cholinergie and cat-
echolaminergic potentials.'oll Dopamine-ß-hydroxy-
lase (DBH) was demonstrated 10 the TH-
immunoreactive cells after double staining (data not 
shown). Recent studies on the prommer region of the 
DBH gene mapped the loeation of DNA sequences 
neeessary for the uanseriptional regulation of the 
DBH gene.l' This information appears relevant to 
produee engineered dopaminergic sympathetic neu-
rones. These cells may be used for brain grafting in the 
ueatment of neurodegenerative diseases eharacterized 
by seleetive impairment of the dopaminergie system, 
sueh as Parkinson's disease. 
Conclusions 
This repon shows that EGF can be used to sclce-
tively induce the proliferation of multipotent progeni-
tor eells from the human embryonie sympathetie 
chain. These cells can differentiate into NGF-respond-
ing neuronal eells. The reported method may be used 
to obtain a large number of eateeholaminergie human 
cells in order to better define the effeets of genetie and 
epigenetic influenees on the SA eell fate definition. 
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